Integer Holdings Corporation (NYSE:ITGR – Get Free Report) Director Cheryl Capps purchased 1,600 shares of the company’s stock in a transaction that occurred on Thursday, November 6th. The shares were purchased at an average cost of $66.70 per share, with a total value of $106,720.00. Following the completion of the purchase, the director owned 11,702 shares of the company’s stock, valued at $780,523.40. The trade was a 15.84% increase in their position. The purchase was disclosed in a filing with the SEC, which can be accessed through this link.
Integer Stock Down 0.5%
Shares of ITGR opened at $69.48 on Thursday. The company has a debt-to-equity ratio of 0.70, a current ratio of 3.71 and a quick ratio of 2.45. The stock has a market capitalization of $2.43 billion, a price-to-earnings ratio of 29.07, a price-to-earnings-growth ratio of 0.60 and a beta of 0.95. Integer Holdings Corporation has a 1 year low of $62.00 and a 1 year high of $146.36. The business’s 50 day simple moving average is $93.23 and its 200-day simple moving average is $107.89.
Integer (NYSE:ITGR – Get Free Report) last posted its earnings results on Thursday, October 23rd. The medical equipment provider reported $1.79 earnings per share for the quarter, beating analysts’ consensus estimates of $1.68 by $0.11. Integer had a net margin of 4.75% and a return on equity of 12.84%. The business’s revenue was up 8.4% on a year-over-year basis. During the same period last year, the firm earned $1.43 earnings per share. Integer has set its FY 2025 guidance at 6.290-6.430 EPS. As a group, equities analysts expect that Integer Holdings Corporation will post 6.01 earnings per share for the current fiscal year.
Wall Street Analysts Forecast Growth
Several brokerages have weighed in on ITGR. Bank of America cut Integer from a “buy” rating to a “neutral” rating and set a $87.00 price objective on the stock. in a research note on Friday, October 24th. Benchmark reissued a “hold” rating on shares of Integer in a research report on Friday, October 24th. Citigroup lowered their price target on Integer from $77.00 to $69.00 and set a “neutral” rating for the company in a research report on Monday, November 3rd. Piper Sandler dropped their price objective on shares of Integer from $155.00 to $82.00 and set an “overweight” rating for the company in a research note on Friday, October 24th. Finally, Weiss Ratings reissued a “hold (c-)” rating on shares of Integer in a research note on Friday, October 31st. Four investment analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the stock. According to MarketBeat.com, Integer has an average rating of “Hold” and an average price target of $96.75.
Read Our Latest Research Report on Integer
Institutional Trading of Integer
Several institutional investors and hedge funds have recently made changes to their positions in the business. Dimensional Fund Advisors LP grew its holdings in shares of Integer by 4.9% in the third quarter. Dimensional Fund Advisors LP now owns 1,410,480 shares of the medical equipment provider’s stock worth $145,738,000 after purchasing an additional 65,865 shares during the last quarter. State Street Corp boosted its position in Integer by 1.0% in the 2nd quarter. State Street Corp now owns 1,326,050 shares of the medical equipment provider’s stock valued at $163,064,000 after buying an additional 13,540 shares during the period. Viking Global Investors LP grew its stake in Integer by 9.1% in the 2nd quarter. Viking Global Investors LP now owns 1,283,965 shares of the medical equipment provider’s stock worth $157,889,000 after acquiring an additional 106,692 shares in the last quarter. Alliancebernstein L.P. increased its position in shares of Integer by 885.1% during the second quarter. Alliancebernstein L.P. now owns 1,106,091 shares of the medical equipment provider’s stock worth $136,016,000 after acquiring an additional 993,810 shares during the period. Finally, Franklin Resources Inc. raised its stake in shares of Integer by 11.5% during the second quarter. Franklin Resources Inc. now owns 907,232 shares of the medical equipment provider’s stock valued at $111,562,000 after acquiring an additional 93,294 shares in the last quarter. 99.29% of the stock is currently owned by institutional investors.
Integer Company Profile
Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.
Featured Articles
- Five stocks we like better than Integer
- How Can Investors Benefit From After-Hours Trading
- Rare Earth Stocks: The Truce That Isn’t a Truce
- What is MarketRank� How to Use it
- Carving Up Profits: 3 Food Stocks on the Thanksgiving Table
- Are Penny Stocks a Good Fit for Your Portfolio?
- C3.ai’s Reset: Why New Leadership Could Spark a Turnaround
Receive News & Ratings for Integer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integer and related companies with MarketBeat.com's FREE daily email newsletter.
